Akanksha Mudgal
Lublin, LU, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ro 64-6198, a selective NOP receptor agonist blocks CGRP-induced migraine-like symptoms and modulates cellular activation.
Journal: Biochemical pharmacology
Published: March 11, 2026
Anti-Inflammatory Potential of Novel Tethered Agonists of the Adhesion G Protein-Coupled Receptor F5.
Journal: International journal of molecular sciences
Published: January 30, 2026
Evaluation of the antimigraine and anti-neuroinflammatory activity of purified constituents of Petasites hybridus L. in a migraine-like pain model in mice.
Journal: Inflammopharmacology
Published: November 21, 2025
Ro 64-6198, a selective NOP receptor agonist attenuates social impairments associated with NTG-induced migraine pain.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
Published: March 12, 2025
Biased signaling via serotonin 5-HT2A receptor: From structural aspects to in vitro and in vivo pharmacology.
Journal: Acta pharmaceutica Sinica. B
Published: March 07, 2025
Unveiling the Therapeutic Potential of D2AAK1 and Its Derivatives: Mechanistic Insights and Applications in Neurodegenerative Disease Treatment.
Journal: Journal of neurochemistry
Published: February 10, 2025
The amniote-conserved DNA-binding domain of CGGBP1 restricts cytosine methylation of transcription factor binding sites in proximal promoters to regulate gene expression.
Journal: BMC genomic data
Published: June 27, 2024
G-quadruplex landscape and its regulation revealed by a new antibody capture method.
Journal: Oncotarget
Published: March 14, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026